Activities on the stock markets and bond markets in Europe have been important during the first half of 2015. This has continued despite the volatility in May and June 2015 and uncertainties regarding Greece. IPO activity is still important and the trend of NASDAQ listings of European biotechs is strengthening, with the listing of two Belgian/Dutch biotechs in the US over the last months.